mscv2.2 Citations (5)
Originally described in: Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity.Kofoed EM, Vance RE Nature. 2011 Aug 28;477(7366):592-5. doi: 10.1038/nature10394. PubMed Journal
Articles Citing mscv2.2
Articles |
---|
A cellular model reflecting the phenotypic heterogeneity of mutant HRAS driven squamous cell carcinoma. Cantarino N, Fernandez-Figueras MT, Valero V, Musulen E, Malinverni R, Granada I, Goldie SJ, Martin-Caballero J, Douet J, Forcales SV, Buschbeck M. Int J Cancer. 2016 Sep 1;139(5):1106-16. doi: 10.1002/ijc.30139. Epub 2016 May 5. PubMed |
Oncogenic Activation of the RNA Binding Protein NELFE and MYC Signaling in Hepatocellular Carcinoma. Dang H, Takai A, Forgues M, Pomyen Y, Mou H, Xue W, Ray D, Ha KCH, Morris QD, Hughes TR, Wang XW. Cancer Cell. 2017 Jul 10;32(1):101-114.e8. doi: 10.1016/j.ccell.2017.06.002. PubMed |
Mitochondria Restrict Growth of the Intracellular Parasite Toxoplasma gondii by Limiting Its Uptake of Fatty Acids. Pernas L, Bean C, Boothroyd JC, Scorrano L. Cell Metab. 2018 Apr 3;27(4):886-897.e4. doi: 10.1016/j.cmet.2018.02.018. PubMed |
Matrix stiffness regulates endosomal escape of uropathogenic E. coli. Moorthy S, Byfield FJ, Janmey PA, Klein EA. Cell Microbiol. 2020 May;22(5):e13196. doi: 10.1111/cmi.13196. Epub 2020 Mar 4. PubMed |
Sensing soluble uric acid by Naip1-Nlrp3 platform. Braga TT, Davanso MR, Mendes D, de Souza TA, de Brito AF, Cruz MC, Hiyane MI, de Lima DS, Nunes V, de Fatima Giarola J, Souto DEP, Prochnicki T, Lauterbach M, Biscaia SMP, de Freitas RA, Curi R, Pontillo A, Latz E, Camara NOS. Cell Death Dis. 2021 Feb 5;12(2):158. doi: 10.1038/s41419-021-03445-w. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.